Chemomab to merge with Scipher Medicine
Seeking Alpha ·
Chemomab Therapeutics ( CMMB ) and Scipher Medicine have entered into a definitive merger agreement pursuant to which the companies will combine in a stock transaction, the companies said on Wednesday. Upon completion of the merger, the combined company expects to operate as
DYAX Investor Sentiment
Bullish (Long) 51% · Bearish (Short) 49%
503 participants
Related News
- Why Sandisk Stock Popped Again Today
- Stocks making big moves yesterday: Penguin Solutions, Kirby, Dell, Broadcom, and Halliburton
- Elon Musk Lost His Trillionaire Status as SpaceX Shares Dropped 26%. Are Tesla and SpaceX Stock Still a Buy?
- Porsche loses traction as sales fall to lowest level in six years
- What Is the Vanguard International Dividend Appreciation ETF (VIGI), and Who Should Buy It?
- Google Search Traffic Peaked After Argentina's World Cup Win Over Egypt